A second Novo Nordisk teammate, David Lozano ... Miller Tour of Utah and USA Cycling. She also founded Bike Alpharetta Inc, a Georgia non-profit to promote safe cycling. She is proud to have ...

Ozempic and related GLP-1 drugs have taken Europe and North America by storm and have quickly become the darling of the ...

Ahead of World Diabetes Day on November 14, the Bangkok Ride & Run 2024 brought together hundreds in support of diabetes ...

The global diabetes crisis is worsening. With over 537 million people currently living with diabetes worldwide, the ...

Healthcare is possibly the most overlooked of all the mega-trends. But this may leave investors with more opportunities once ...

It started as a group of six – Pasqualon, Simon Yates (Jayco-AlUla), Masai Yamamoto (JCL Team UKYO), Georg Steinhauser (EF Education-EasyPost), Hamish Beadle (Novo Nordisk) and Iribe Shotaro ...

You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists ...

Novo Nordisk said the side effects in trials so far for its experimental obesity drug CagriSema were similar to its GLP-1 ...

EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...

Novo Nordisk's blockbuster drugs Ozempic and Wegovy have slimmed down Hollywood stars and millions of non-celebrities ...

LONDON, Nov 6 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab chief financial officer Karsten Munk Knudsen said on Wednesday the company was aware of reports of 10 deaths and 100 ...

Novo Nordisk acquires exclusive worldwide license to Ascendis Pharma’s TransCon technology for developing metabolic and ...